vimarsana.com

Page 22 - எங்களுக்கு தேசிய நூலகம் ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Biological Seed Treatment Market (2021 to 2026) - Featuring BASF, Bayer and Syngenta Among Others

Global Biological Seed Treatment Market (2021 to 2026) - Featuring BASF, Bayer and Syngenta Among Others
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Global Biological Seed Treatment Market (2021 to 2026) - Featuring BASF, Bayer and Syngenta Among Others

Global Biological Seed Treatment Market (2021 to 2026) - Featuring BASF, Bayer and Syngenta Among Others
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Vaccines Vials Market Size is Projected to reach USD 901 3 Million by 2027, Says Brandessence Market Research

(0) LONDON, May 20, 2021 /PRNewswire/ The global vaccines vials market in terms of revenue was worth of USD 459.6 Million in 2020 and is expected to reach USD 901.3 Million in 2027, growing at a CAGR of 10.1% from 2021 to 2027. The global vaccines vials market is expected to grow at a significant growth rate due to several driving factors. The study provides a crucial view of the global vaccines vials market by segmenting the market based on dose, material, technology, applications, capacity and region & country level. Based upon the dose, global vaccines vials market is segmented into single dose and multi dose. Based upon material, the global vaccines vials market is classified into glass and polymer in which glass is sub divided into medium borosilicate glass vials, low borosilicate glass vials, and soda lime glass vials. Based upon technology, the market is segmented into molded vials, tubular vials and others. Based upon applications, the global vaccines vials market is cate

Black fungus treatment runs short in India as new cases of infection emerge

(Image credit: Shutterstock) New cases of mucormycosis, a potentially fatal fungal infection, continue to crop up among COVID-19 patients in India, but many regions are facing shortages of the drug used to treat the disease. Mucormycosis, also called black fungus, typically strikes people with weakened diabetes and those taking immunosuppressive drugs including the steroids sometimes used to treat COVID-19, Live Science previously reported. Experts suspect that the rise in cases may be to these steroids, administered both in hospitals and sometimes at home, as hospitals have recently been overrun. In addition, those receiving medicine or oxygen therapy at home may be more likely to pick up the mold from their surroundings, compared with those treated in a sterile, clinical setting.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.